Identification of breast cancer metastasis-associated genes by chip technology

Anticancer Research

Volumn 21, Issue 6 A, 2001, Pages 3799-3806

  Evtimova, Vesna ^a   Schwirzke, Marina ^a   Tarbé, Nesrine ^a   Burtscher, Helmut ^a   Jarsch, Michael ^a   Kaul, Sepp ^a   Weidle, Ulrich H ^a  

^a ROCHE DIAGNOSTICS GMBH   (Germany)

Author keywords

Cytoskeleton; Extracellular matrix; Gene deregulation; Motility and invasion; Pathway analysis; Transcriptional profiling; Tumor suppressor genes

Indexed keywords

ARTICLE; ASCITES TUMOR; BONE MARROW METASTASIS; BREAST CANCER; CANCER CELL CULTURE; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC IDENTIFICATION; GENETIC LINKAGE; HUMAN; HUMAN CELL; LYMPH NODE METASTASIS; PATHOGENESIS; PRIORITY JOURNAL; TECHNOLOGY;

BONE MARROW NEOPLASMS; BREAST NEOPLASMS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHATIC METASTASIS; NEOPLASM METASTASIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0035570756     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. New genes potentially involved in breast cancer metastasis
2. Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring
3. Identification by cDNA microarray of genes involved in ovarian carcinogenesis
4. Transcriptional profiling of human mammary carcinoma cell lines reveals PKW, a new tumor-specific gene
5. Role of insulin-like growth factor-I (IGF-I) receptor, IGF-1 and IGF binding protein-2 in human colorectal cancers
6. Overexpression of insulin-like growth factor-binding protein-2 results in increased tumorigenic potential in Y-1 adrenocortical tumor cells
7. Increased levels of insulin-like growth factor II (IGF-II) and IGF-binding protein-2 are associated with malignancy in sporadic adrenocortical tumors
8. Reactivation of insulin-like growth factor binding protein 2 expression in glioblastoma multiforme: A revelation by parallel gene expression profiling
9. Localization of the gene coding for myosin phosphatase, target subunit 1 (MYPT1) to human chromosome 12q15-q21
10. Erythrocyte protein 4.1 associates with tubulin
11. The TACC domain identifies a family of centrosomal proteins that interact with microtubules
12. Cloning of TACC 1, an embryonically expressed, potentially transforming coiled coil containing gene, from the 8p11 breast cancer amplicon
13. Identification and chromosomal localization of CTNNAL1, a novel protein homologous to alpha-catenin
14. Human alpha-catulin, a novel alpha-catenin-like molecule with conserved genomic structure, but deviating alternative splicing
15. Cloning and characterization of p97MAPK, a novel human homolog of rat ERK-3
16. Histone macroH 2A1 is concentrated in the inactive X chromosome of female mammals
17. Radioimmunoassay of serum creatine kinase-BB as a tumour marker in breast cancer
18. The significance of creatine kinase (CKBB) in metastatic cancer of the prostate
19. Expression of brain-type glycogen phosphorylase is a potentially novel early biomarker in the carcinogenesis of human colorectal carcinomas
20. Carcinogenesis of intestinal-type gastric cancer and colorectal cancer is commonly accompanied by expression of brain (fetal)-type glycogen phosphorylase
21. Elevated concentrations of brain-type glycogen phosphorylase in renal cell carcinoma
22. Identification of I-plastin, a human fimbrin isoform expressed in intestine and kidney
23. Multiple cadherin superfamily members with unique expression profile are produced in rat testis
24. Semaphorins act as attractive and repulsive guidance signals during the development of cortical projections
25. Identification of semaphorin E as a non-MDR drug resistance gene of human cancers
26. Thrombospondin-1 (TSP-1) promotes the invasive properties of human breast cancer
27. Thrombospondin modulates human breast adenocarcinoma cell adhesion to human vascular endothelial cells
28. Involvement of thrombospondin in the adherence of human breast adenocarcinoma cells: A possible role in the metastatic process
29. Thrombospondin levels in patients with malignancy
30. RACK1 is up-regulated in angiogenesis and human carcinomas
31. Identification of glycosylated 38-kDa connective tissue growth factor (IGFBP-related protein 2) and proteolytic fragments in human biological fluids, and up-regulation of IGFBP-rP2 expression by TGF-beta in Hs 578T human breast cancer cells
32. Expression of connective tissue growth factor mRNA in the fibrous stroma of mammary tumors
33. Activated leukocyte cell adhesion molecule / CD 166, a marker of tumor progression in primary malignant melanoma of the skin
34. Cystatin C and cathepsin B in human colon carcinoma: Expression by cell lines and matrix degradation
35. Cloning and characterization of GRB14, a novel member of the GRB7 gene family
36. Association of fibroblast growth factor receptor 1 with the adaptor protein Grb14. Charaterization of a new receptor binding partner
37. Volume-sensitive KCl cotransport associated with human cervical carcinogenesis
38. Cyclooxygenase-1 and -2 isoenzymes
39. Chemoprevention of breast cancer by celecoxib, a cyclooxygenase 2 inhibitor
40. Complement resistance of tumor cells: Basal and induced mechanisms
41. Developmental expression pattern of Stra6, a retinoic acid-responsive gene encoding a new type of membrane protein
42. Tazarotene-induced gene 1 (TIG1), a novel retinoic acid receptor-responsive gene in skin
43. Novel insights into structure and function of MRP8 (S100A8) and MRP14 (S100A9)
44. The cellular retinoic acid binding protein II is a positive regulator of retinoic acid signaling in breast cancer cells
45. The growth suppressing gas1 product is a GPI-linked protein
46. Identification of a novel gene, LDOC1, down-regulated in cancer cell lines
47. Imprinting and expression of insulin-like growth factor-II and H19 in normal breast tissue and breast tumor
48. TGFbeta regulation of mitogen-activated protein kinases in human breast cancer cells
49. Transforming growth factor beta 2 (TGF-beta 2) levels in plasma of patients with metastatic breast cancer treated with tamoxifen
50. Melanoma cells constitutively release an anchor-positive soluble form of protectin (sCD59) that retains functional activities in homologous complement-mediated cytotoxicity